Cardiff Oncology (CRDF) Research & Development (2011 - 2026)
Cardiff Oncology (CRDF) recorded Research & Development of $5.92 million in Q2 2026, down 48.9% from $11.58 million a year earlier.
Powered by 
Analysis
Cardiff Oncology (CRDF) Research & Development (2011 - 2026) Analysis & Trends
On a TTM basis, Cardiff Oncology's Research & Development came in at $30.77 million as of Jun 30, 2026, down 25.7% year-over-year; for FY2025, it was $35.33 million, down 4.1% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 25.8% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $36.85 million in FY2024 (+12.2%), $32.86 million in FY2023 (+21.2%), $27.11 million in FY2022 (+56.0%) and $17.38 million in FY2021 (+54.7%).
- Quarterly Research & Development has ranged from $4.15 million in Q3 2021 to $11.58 million in Q2 2025 over the past five years.
- On a year-over-year basis, Research & Development rose in four of the last seven quarters, with an average decline of 1.9%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 119.8% in Q1 2022, against a decline of 48.9% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Cardiff Oncology | 54.12 Mn | 19.62 Mn | - | 5.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.92 Mn |
| Mar 31, 2026 | 6.77 Mn |
| Dec 31, 2025 | 5.08 Mn |
| Sep 30, 2025 | 8.20 Mn |
| Jun 30, 2025 | 11.58 Mn |
| Mar 31, 2025 | 10.48 Mn |
| Dec 31, 2024 | 9.71 Mn |
| Sep 30, 2024 | 9.64 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Mar 31, 2024 | 8.01 Mn |
| Dec 31, 2023 | 7.76 Mn |
| Sep 30, 2023 | 8.02 Mn |
| Jun 30, 2023 | 8.02 Mn |
| Mar 31, 2023 | 9.05 Mn |
| Dec 31, 2022 | 6.44 Mn |
| Sep 30, 2022 | 6.01 Mn |
| Jun 30, 2022 | 7.45 Mn |
| Mar 31, 2022 | 7.21 Mn |
| Dec 31, 2021 | 5.82 Mn |
| Sep 30, 2021 | 4.15 Mn |
API Access
Cardiff Oncology Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CRDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();